Continuing Education Requirements Update

Posted in Latest News on June 15, 2018.

Rule 64B16-27.831(6), Florida Administrative Code, related to “Standards of Practice for the Filling of Controlled Substance Prescriptions; Electronic Prescribing; Mandatory Continuing Education” has been amended, with an effective date of June 14, 2018. This rule now provides that all licensed pharmacists shall complete a Board-approved 2-hour continuing education course, on the “Validation and Counseling of Prescriptions for Controlled Substances and Opioids”, during the biennium ending on September 30, 2019. This 2-hour course shall be taken every biennium thereafter.

The “Validation and Counseling of Prescriptions for Controlled Substances and Opioids” course shall count towards the mandatory 30 hours of CE required for licensure renewal, and all newly licensed pharmacists must complete the required course before the end of the first biennial renewal period. A licensee who completes the mandated “Validation and Counseling of Prescriptions for Controlled Substances and Opioids” course between October 1, 2017 and July 1, 2018, shall be deemed to have complied with this subsection for the biennium ending on September 30, 2019.

After July 1, 2018, any CE course offered on this subject, by a Board-approved CE provider, must contain the new CE requirements contained within Rule 64B16-27.831, F.A.C., in order for the licensee to obtain credit for the course during the current biennium ending on September 30, 2019. Please note that if the content for a current course offered on “Validation and Counseling of Prescriptions for Controlled Substances and Opioids” by a Board-approved CE provider is not amended to include the new amendments to Rule 64B16-27.831, F.A.C., effective as of June 14, 2018, the course may only be approved for general CE credit only.

If you have any additional questions, please contact the Florida Board of Pharmacy Office at (850)245-4292, or via e-mail at: MQA.Pharmacy@flhealth.gov.

A copy of the new rule be found at the following link:

https://www.flrules.org/gateway/RuleNo.asp?title=PHARMACY PRACTICE&ID=64B16-27.831



More Latest News

Important notice regarding Rhopressa
February 12, 2019

The board approved Rhopressa (netarsudil ophthalmic solution) 0.02% for addition to Rule 64B13-18.002. Effective January 25, 2019, Licensees are now permitted to prescribe Rhopressa. Continue reading


Florida Jurisprudence CE Requirement
February 11, 2019

The Board of Optometry voted to waive the 2-hour Florida Jurisprudence requirement for all out-of-state licensees for the current biennium only. Click Here for more information. Continue reading